|
Someone bought up big today:
Visiomed Group Limited (VSG)
Date Time Price
($) Quantity Value ($) Conditions
27-04-2004 02:51 PM $0.064 150000
$9,600.000
27-04-2004 02:29 PM $0.064 10000 $640.000
27-04-2004 02:29 PM $0.064 50000 $3,200.000
27-04-2004 01:56
PM $0.065 38180 $2,481.700
27-04-2004 12:42
PM $0.062 2107388 $130,658.056 Crossed
27-04-2004 12:29 PM
$0.062 68500 $4,247.000
27-04-2004 12:26 PM $0.063 31500
$1,984.500 Crossed
27-04-2004 10:30 AM $0.063 8500 $535.500 Crossed
27-04-2004 10:23 AM $0.063 91500 $5,764.500
26-04-2004 03:40
PM $0.064 100000 $6,400.000
----- Original Message -----
Sent: Tuesday, April 27, 2004 1:57
PM
Subject: Re: [sharechat] VSG Upside
Potential Looking Good.
ASX: VSG - Update lodged with ASX today at
12.38pm
| VSG |
12:38 PM |
|
On track for FDA Clearance of
Microderm Submission |
----- Original Message -----
Sent: Tuesday, April 20, 2004 3:53
PM
Subject: Re: [sharechat] VSG Upside
Potential Looking Good.
I have asked Visiomed when shareholders can expect an
update.
Visiomed will be posting out a newsletter to shareholders in
the near future.
----- Original Message -----
Sent: Monday, April 19, 2004 7:53
AM
Subject: Re: [sharechat] VSG Upside
Potential Looking Good.
FDA application has been lodged - approval
was anticipated around late April.
Everyone here knows my thoughts on this
one.
My expert TA analysis - higher highs,
higher lows and poised for another upturn especially in consideration of
anticipated FDA approval.
----- Original Message -----
Sent: Monday, April 19, 2004 5:46
AM
Subject: [sharechat] VSG Upside
Potential Looking Good.
Latest April 04 Aegis Equities Comments.
Through
the acquisition of Visiomed AG, VSG has not only secured full
control over the microDERM device but also has rights to any other
IP
developed within the German company. This includes some
interesting surgical
navigation technology that VSG may be able to
commercialise in the future.
The Funhaler provides a potential
spinout product that can help fund VSG's
other ventures.
VSG
has managed to build its patent portfolio over the last year, an
important first step to eventual commercialisation. A recent study
was
published in the influential British Journal of Dermatology
detailing the
diagnostic use of the MicroDERM system and this should
help it achieve US
regulatory approval as higher value diagnostic
device. VSG also forged
closer links with Siemens AG, one of the
world's largest and most recognised
engineering and medical imaging
companies, announcing an exclusive
Australian dealership for a range
of Siemens medical imaging systems. VSG is
also a significant
participating collaborator with Siemens in the
development of
ultrasound-based surgical navigation systems for spinal
procedures.
Lazy
Haggis
_________________________________________________________________
Watch
LIVE baseball games on your computer with MLB.TV, included with MSN
Premium!
http://join.msn.com/?page=features/mlb&pgmarket=en-us/go/onm00200439ave/direct/01/
----------------------------------------------------------------------------
To
remove yourself from this list, please use the form at
http://www.sharechat.co.nz/chat/forum/
|
See IRG research reports
